Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population

被引:0
作者
Takahiro Matsuno
Hideaki Matsuura
Sumie Fujii
Ryoka Suzuki
Yukari Sugiura
Yasuo Miura
机构
[1] Fujita Health University Hospital,Department of Blood Transfusion
[2] Fujita Health University School of Medical Sciences,Department of Molecular Laboratory Medicine
[3] Fujita Health University School of Medicine,Department of Transfusion Medicine and Cell Therapy
来源
International Journal of Hematology | 2022年 / 115卷
关键词
Delayed hemolytic transfusion reaction; Irregular antibody; Red blood cell transfusion; Human leukocyte antigen;
D O I
暂无
中图分类号
学科分类号
摘要
A 43-year-old Japanese male, who had undergone open liver surgery for tumor resection, presented with decreased hemoglobin levels on Day 13 post-emergency-release transfusion of 16 units of Fy(a +) red blood cells. As the anemia was accompanied by increased lactate dehydrogenase, indirect bilirubin, and reticulocytes, as well as decreased haptoglobin, it was attributed to hemolysis. In the diagnostic workup for hemolytic reaction, the direct antiglobulin test result for IgG was positive and the antibody dissociated from the patient’s peripheral red blood cells was identified as anti-Fya (titer, 4). The hemolytic reaction was transient (approximately 10 days), of moderate severity, and did not result in any obvious organ damage. However, a single compatible red blood cell transfusion of 2 units was required on Day 17 after the causative transfusion. Notably, HLA typing revealed that the patient carried the HLA-DRB1*04:03 allele, which has been implicated in immunogenicity and induction of anti-Fya response in Caucasian populations. In summary, this is the first documented case of definitive anti-Fya-mediated delayed hemolytic transfusion reaction associated with HLA-DRB1*04:03 in the Japanese population.
引用
收藏
页码:440 / 445
页数:5
相关论文
共 71 条
[1]  
Moore SB(1980)Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test Am J Clin Pathol. 74 94-7
[2]  
Taswell HF(1993)Delayed hemolytic transfusion reaction during past ten years Jpn J Trans Med 39 974-978
[3]  
Pineda AA(2006)Prevention and diagnosis of delayed haemolytic transfusion reactions Vox Sang 91 365-367
[4]  
Sonnenberg CL(1950)A new human blood group Nature 165 188-189
[5]  
Sawabe T(1951)Discovery of the expected haemagglutinin, anti-Fyb Nature 168 1077-1078
[6]  
Miya T(2000)The Duffy protein: a malarial and chemokine receptor Semin Hematol 37 122-129
[7]  
Yashiro T(2005)High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population Immunogenetics 57 717-729
[8]  
Takayama J(2020)Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data J Proteome Res 19 2304-2315
[9]  
Tobinai K(1961)A critique of the theorical hazard of inter vs intra-racial transfusion Transfusion 1 233-238
[10]  
Takenaka T(2000)Identification of alloreactive T-cell epitopes on the Rhesus D protein Blood 96 4011-4019